ID
28262
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Hospitalisation - Repeating form (Scheduled visits)
Keywords
Versions (4)
- 9/27/17 9/27/17 -
- 10/4/17 10/4/17 -
- 10/23/17 10/23/17 -
- 1/1/18 1/1/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
January 1, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Hospitalisation Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
Hospitalisation Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
Description
Discharge diagnoses
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1]
- C2348184
Description
Diagnosis at discharge
Data type
text
Alias
- UMLS CUI [1]
- C1555319
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1]
- C2826302
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1,1]
- C0871468
- UMLS CUI [1,2]
- C1518404
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1]
- C3898442
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
Description
Diagnosis type
Data type
integer
Alias
- UMLS CUI [1]
- C1550351
Similar models
Hospitalisation Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
C1518404 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)